Injectable hydrogels |
DMARDs |
Methotrexate |
Combining black phosphorus nanosheets and platelet-rich plasma-chitosan thermoresponsive hydrogel |
Excellent ability of drug releasing.Thermoresponsive |
Pan et al. (2020)
|
Injectable hydrogels |
DMARDs |
Methotrexate |
In situ gelation and employ Au NPs |
Improved cytocompatibility,modulus and cell adhesion;Excellent ability of drug releasing |
Nutan et al. (2020)
|
Injectable hydrogels |
DMARDs |
Methotrexate |
GDFDFDY were used to create a supramolecular self-assembling hydrogel |
The excellent ability to control the proliferation and migration of rheumatoid arthritis synoviocytes |
Ma et al. (2022)
|
Injectable hydrogels |
DMARDs |
Methotrexate |
A novel click-crosslinked HA (Cx-HA) depot was developed through the click crosslinking reaction between tetrazine-modified HA and trans-cyclooctene-modified HA |
Excellent ability of drug releasing |
Seo et al. (2019)
|
Injectable hydrogels |
DMARDs |
Methotrexate |
Oligochitosan and hypromellose phthalate-based polyelectrolyte complexes |
Thermosensitive.Excellent ability of drug releasing. |
Agostini et al. (2021)
|
Injectable hydrogels |
DMARDs |
Methotrexate |
Methotrexate and transforming growth factor β1 are loaded in nano-Fe3O4 composite chitosan-polyolefin to construct a multifunctional hydrogel |
Inhibit inflammation and promote cartilage regeneration.Excellent mechanical properties |
Gang et al. (2021)
|
Injectable hydrogels |
DMARDs |
Methotrexate |
The MTX and HA loaded drug-encapsulating NPs based on PLGA and DOTA were combined to synthesize the 177Lu-DOTA-HA-PLGA (MTX) |
Bi-modal mechanisms of treatment through Lutetium177 and MTX. |
Trujillo-Nolasco et al. (2019)
|
Transdermal hydrogels |
DMARDs |
Methotrexate |
Creating the PCL- PEG-PCL triblock copolymer through the reaction of ring opening copolymerization and applied it in the delivery of the fabrication loaded with MTX nanomicelles |
Nanomicelles loaded;excellent non-newtonian property;the ability to overcome the skin barrier and relese the drug in a sustain way |
Qindeel et al. (2020a)
|
Transdermal hydrogels |
DMARDs |
Methotrexate |
Combining a patch-like reservoir loaded with MTX (MTX-RV) and the hydrogel-forming microneedle arrays (HFMN) |
The ability to overcome the skin barrier and relese the drug in a sustain way.Negligible side effects on skin |
Tekko et al. (2020)
|
Injectable hydrogels |
DMARDs |
Iguratimod |
Encapsulating IGUR in biodegradable polyvinyl alcohol micelles and load it into the in situ injected hyaluronic acid hydrogels |
Excellent mechanical properties and the ability of drug releasing |
Ma et al. (2019)
|
Injectable hydrogels |
NSAIDs |
Ketoprofen |
Transforming the anti-inflammatory drug ketoprofen into the self-assembled products through covalent conversion |
Excellent ability of drug loading and releasing |
Chen et al. (2017)
|
Transdermal hydrogels |
NSAIDs |
Ibuprofen |
The Eudragit® L 100 (EL 100) NPs containing IB were loaded into Carbopol? 934-based hydrogel |
PH-responsive.The ability to overcome the skin barrier and relese the drug in a sustain way |
Khan et al. (2021)
|
Transdermal hydrogels |
NSAIDs |
Aceclofenac |
Nanostructured lipid carrier (NLC)-based ACE (ACE-NLC) hydrogel |
The ability to overcome the skin barrier and relese the drug in a sustain way.Nanoscale lipid carrier |
Garg et al. (2021) |
Injectable hydrogels |
Glucocorticoids |
Glucocorticoids |
Combining the thermo-responsive hydrogels with microparticles |
Pseudoplastic behaviors.Good biological adhesion.The ability of sustain drug releasing |
Abou-EiNour et al. (2020)
|
Injectable hydrogels |
Anti-TNF-α drugs |
Anti-TNF-α drugs |
A promising drug system based on anti-TNF-α chondroitin sulfate (CS) modified poly(amidoamine) (CS/PAMAM) dendrimer NPs |
Good biocompatibility.Nanoscale lipid carrier |
Oliveira et al. (2021)
|
Injectable hydrogels |
Anti-TNF-α drugs |
Infliximab |
Incorporating the infliximab into a thermoresponsive hydrogel synthetized by combining the pluronic F127 and HA with poly (γ-glutamic acid) (PGA) |
Excellent biodegradability, biocompatibility, and the ability to continuously release |
Chen et al. (2020)
|
Injectable hydrogels |
Chinese medicine preparation |
Sanwujiaowan |
Constructing the deep eutectic solvent (DEC) extract complex by heating the herb extracts with amino acid and citric acid.Then the DES-extract complex was introduced into the suitable hydrogel |
Improved viscoelastic and mechanical properties |
Xiao et al. (2022)
|
Injectable hydrogels |
Chinese medicine preparation |
Triptolide |
The HA hydrogel-loaded RGD-attached AuNPs containing the TP |
Nanoscale lipid carrier.Delivering heat and drugs simultaneously |
Li et al. (2022)
|
Injectable hydrogels |
Chinese medicine preparation |
2-chloro-N(6)-cyclopentyl adenosine |
Combining the nanocomposite hydrogel and acupuncture to improve the applications of TP in rheumatoid arthritis |
The hydrogel was administrated at ST36 with a controllable and sustained release of drugs |
Ren et al. (2021)
|
Injectable hydrogels |
Multiple drugs |
Indomethacin and methotrexate |
A temperature-sensitive hydrogel (D-NGel) containing nanoparticles (D-NPs), simultaneously delivering IND and MTX |
Temperature-sensitive.Co-delivery of indomethacin and methotrexate |
Yin et al. (2020)
|
Injectable hydrogels |
Cells |
ADMSCs |
A kind of hydrogel with the ability of self-healing through the dynamic reactions between infliximab and modified polysaccharides |
self-healable, anti-inflammatory, biocompatible, and biodegradable properties |
Zhao et al. (2021)
|